Series D1
Corxel Pharmaceuticals Raises $287M Series D1 to Advance Oral GLP-1 Obesity Drug CX11
Corxel Pharmaceuticals; Series D1; GLP-1; CX11; obesity drug; funding; Vincentage
Actionable Insights Powered by AI
Corxel Pharmaceuticals; Series D1; GLP-1; CX11; obesity drug; funding; Vincentage